|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 5 (March 1), 2000:
pp. 1788-1796
FGFR1 is fused to the centrosome-associated protein
CEP110 in the 8p12 stem cell myeloproliferative disorder with
t(8;9)(p12;q33)
Géraldine Guasch,
Gary J. Mack,
Cornel Popovici,
Nicole Dastugue,
Daniel Birnbaum,
Jérome B. Rattner, and
Marie-Josèphe Pébusque
From the Laboratoire d'Oncologie Moléculaire, Inserm U119,
Institut de Cancérologie et d'Immunologie de Marseille,
Marseille, France; the University of Calgary, Alberta, Canada; the
Laboratoire des Hémopathies, Hôpital de Purpan, Toulouse,
France; and the Laboratoire de Biologie des Tumeurs, Institut
Paoli-Calmettes, Marseille, France
The hallmark of the 8p12 stem cell myeloproliferative disorder (MPD)
is the disruption of the FGFR1 gene, which encodes a tyrosine
kinase receptor for members of the fibroblast growth factor family.
FGFR1 can be fused to at least 3 partner genes at chromosomal
regions 6q27, 9q33, or 13q12. We report here the cloning of the
t(8;9)(p12;q33) and the detection of a novel fusion betweenFGFR1 and the CEP110 gene, which codes for a
novel centrosome-associated protein with a unique cell-cycle
distribution. CEP110 is widely expressed at various levels in
different tissues and is predicted to encode a 994-amino acid
coiled-coil protein with 4 consensus leucine zippers
[L-X(6)-L-X(6)-L-X(6)-L]. Both reciprocal fusion transcripts are
expressed in the patient's cells. The CEP110-FGFR1 fusion protein
encodes an aberrant tyrosine kinase of circa 150-kd, which retains most
of CEP110 with the leucine zipper motifs and the catalytic domain of
FGFR1. Transient expression studies show that the CEP110-FGFR1 protein
has a constitutive kinase activity and is located within the cell cytoplasm.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Dong, S. Kang, T.-L. Gu, S. Kardar, H. Fu, S. Lonial, H. J. Khoury, F. Khuri, and J. Chen
14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells
Blood,
July 1, 2007;
110(1):
360 - 369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Perez de Castro, G. de Carcer, and M. Malumbres
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Carcinogenesis,
May 1, 2007;
28(5):
899 - 912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-L. Gu, V. L. Goss, C. Reeves, L. Popova, J. Nardone, J. MacNeill, D. K. Walters, Y. Wang, J. Rush, M. J. Comb, et al.
Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia
Blood,
December 15, 2006;
108(13):
4202 - 4204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Finch and J. S. Rubin
Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.
J Natl Cancer Inst,
June 21, 2006;
98(12):
812 - 824.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Delaval, S. Letard, H. Lelievre, V. Chevrier, L. Daviet, P. Dubreuil, and D. Birnbaum
Oncogenic Tyrosine Kinase of Malignant Hemopathy Targets the Centrosome
Cancer Res.,
August 15, 2005;
65(16):
7231 - 7240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kim, S R Herrick, E Lemyre, S Kishikawa, J A Salisz, S Seminara, M E MacDonald, G A P Bruns, C C Morton, B J Quade, et al.
Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1
J. Med. Genet.,
August 1, 2005;
42(8):
666 - 672.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. W.M. van Hinsbergh and T. J. Rabelink
FGFR1 and the Bloodline of the Vasculature
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2005;
25(5):
883 - 886.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Reiter, C. Walz, A. Watmore, C. Schoch, I. Blau, B. Schlegelberger, U. Berger, N. Telford, S. Aruliah, J. A. Yin, et al.
The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2
Cancer Res.,
April 1, 2005;
65(7):
2662 - 2667.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Maeda, F. Yagasaki, M. Ishikawa, N. Takahashi, and M. Bessho
Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML
Blood,
March 1, 2005;
105(5):
2115 - 2123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Chen, D. J. DeAngelo, J. L. Kutok, I. R. Williams, B. H. Lee, M. Wadleigh, N. Duclos, S. Cohen, J. Adelsperger, R. Okabe, et al.
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
PNAS,
October 5, 2004;
101(40):
14479 - 14484.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Vizmanos, F. J. Novo, J. P. Roman, E. J. Baxter, I. Lahortiga, M. J. Larrayoz, M. D. Odero, P. Giraldo, M. J. Calasanz, and N. C. P. Cross
NIN, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder1
Cancer Res.,
April 15, 2004;
64(8):
2673 - 2676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gotlib, J. Cools, J. M. Malone III, S. L. Schrier, D. G. Gilliland, and S. E. Coutre
The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Blood,
April 15, 2004;
103(8):
2879 - 2891.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, B. Delaval, C. Arnoulet, M.-J. Xie, L. Xerri, D. Sainty, D. Birnbaum, and M.-J. Pebusque
FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice
Blood,
January 1, 2004;
103(1):
309 - 312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gromley, A. Jurczyk, J. Sillibourne, E. Halilovic, M. Mogensen, I. Groisman, M. Blomberg, and S. Doxsey
A novel human protein of the maternal centriole is required for the final stages of cytokinesis and entry into S phase
J. Cell Biol.,
May 12, 2003;
161(3):
535 - 545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pardanani, T. Reeder, L. F. Porrata, C.-Y. Li, H. D. Tazelaar, E. J. Baxter, T. E. Witzig, N. C. P. Cross, and A. Tefferi
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
Blood,
May 1, 2003;
101(9):
3391 - 3397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, C. Popovici, F. Mugneret, M. Chaffanet, P. Pontarotti, D. Birnbaum, and M.-J. Pebusque
Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3)
Blood,
January 1, 2003;
101(1):
286 - 288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rosati, R. La Starza, A. Veronese, A. Aventin, C. Schwienbacher, T. Vallespi, M. Negrini, M. F. Martelli, and C. Mecucci
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)
Blood,
May 15, 2002;
99(10):
3857 - 3860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Y. Ou, G. J. Mack, M. Zhang, and J. B. Rattner
CEP110 and ninein are located in a specific domain of the centrosome associated with centrosome maturation
J. Cell Sci.,
January 5, 2002;
115(9):
1825 - 1835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Demiroglu, E. J. Steer, C. Heath, K. Taylor, M. Bentley, S. L. Allen, P. Koduru, J. P. Brody, G. Hawson, R. Rodwell, et al.
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins
Blood,
December 15, 2001;
98(13):
3778 - 3783.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guasch, V. Ollendorff, J.-P. Borg, D. Birnbaum, and M.-J. Pebusque
8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways
Mol. Cell. Biol.,
December 1, 2001;
21(23):
8129 - 8142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Magnusson, K. E. Meade, K. E. Brown, D. C. Arthur, L. A. Krueger, A. J. Barrett, and C. E. Dunbar
Rabaptin-5 is a novel fusion partner to platelet-derived growth factor {beta} receptor in chronic myelomonocytic leukemia
Blood,
October 15, 2001;
98(8):
2518 - 2525.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
